The correlation of Banff scoring with reversibility of first and recurrent rejection episodes

Transplantation

Volumn 61, Issue 12, 1996, Pages 1711-1715

  Gaber, Lillian W ^a   Schroeder, Timothy J ^b   Moore, Linda W ^b   Shakouh Amiri, M Hosein ^b   Gaber, A Osama ^b  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN; HLA ANTIGEN; LYMPHOCYTE ANTIBODY; OKT 3; STEROID; THYMOCYTE ANTIBODY;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; GRAFT REJECTION; HLA MATCHING; HUMAN; HUMAN TISSUE; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY BIOPSY; KIDNEY FUNCTION; MICROSCOPY; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; SCORING SYSTEM;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; BIOPSY; GRAFT REJECTION; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS; SEVERITY OF ILLNESS INDEX;

EID: 0029946523     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199606270-00008     Document Type: Article

References (30)

1. Gierton DH. In: Terasaki PI, ed. The UNOS scientific renal transplant registry in clinical transplants UCLA. Los Angeles: UCLA Tissue Typing Laboratory, 1992; 7.
2. Schweitzer EJ, Matas AJ, Gillingham KJ, et al. Causes of renal allograft loss. Ann Surg 1991; 214: 679.
3. United States renal data system, 1993 annual report. Bethesda, MD: National Institutes of Health, 1993: 19.
4. Foster MC, Wenham PW, Rowe PA, et al. The late results of renal transplantation and the importance of chronic rejection as a cause of graft loss. Ann R Coll Surg Eng 1989; 71: 44.
5. Almond PS, Matas AJ, Gillingham KJ, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
6. Matas AJ. Chronic rejection in renal transplant recipients - risk factors and correlates. Clin Transplant 1994; 8: 332.
7. Ferguson R. Acute rejection episodes - Best predictor of long-term primary cadaveric renal transplant survival. Clin Transplant 1994; 8: 328.
8. Yilmaz S, Hayry P. The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. Transplantation 1993; 56: 1153.
9. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
10. Solez K, Marcussen N, Racusen L, et al. Reproducibility of the Banff classification of early renal allograft biopsies. Transplant Proc 1995; 27: 1009.
11. Gaber LW, Moore LW, Alloway RR, et al. Clinical applicability of the Banff classification for acute renal rejection. J Am Soc Nephrol 1993; 4: 935.
12. Gaber LW, Moore LW, Alloway RR, et al. Correlation between Banff classification, acute renal rejection scores and reversal of rejection. Kidney Int 1996; 49, in press.
13. Rush DN, Henry SF, Jeffery JR, et al. Histological findings in early routine biopsies of stable renal allograft recipients. Transplantation 1994; 57: 208.
14. Parfrey PS, Kuo YL, Hanley JA, et al. The diagnostic and prognostic value of renal allograft biopsy. Transplantation 1984; 38: 586.
15. Durand D, Segonds A, Orfila C, et al. Transplant biopsies and short-term outcome of cadaveric renal allografts. Adv Nephrol Necker Hosp (United States) 1983; 12: 309.
16. Kiaer H, Hansen HE, Olsen S. The predictive value of percutaneous biopsies from human renal allografts with early impaired function. Clin Nephrol 1980; 13: 58.
17. Banfi G, Imbasciati E, Tarantino A, et al. Prognostic value of renal biopsy in acute rejection of kidney transplantation. Nephron 1981; 28: 222.
18. Hsu AC, Arbus GS, Noriega E, et al. Renal allograft biopsy: a satisfactory adjunct for predicting renal function after graft rejection. Clin Nephrol 1976; 5: 260.
19. Schroeder TJ, Weiss MA, Smith RD, et al. The efficacy of OKT3 in vascular rejection. Transplantation 1991; 51: 312.
20. Salmela KT, von Willebrand EO, Kyllonen LEJ, et al. Acute vascular rejection in renal transplantation - diagnosis and outcome. Transplantation 1992; 54: 858.
21. Delaney VB, Campbell WG Jr, Nasr SA, et al. Efficacy of OKT3 monoclonal antibody therapy in steroid-resistant, predominantly vascular acute rejection. Transplantation 1988; 45: 743.
22. Cecka JM. Early rejection: determining the fate of renal transplants. Transplant Proc 1991; 23: 1263.
23. Matas AJ, Gillingham KJ, Payne WD, et al. The impact of acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57: 857.
24. Basadonna GP, Matas AJ, Gillingham KJ, et al. Early versus late acute renal allograft rejection: impact on chronic rejection. Transplantation 1993; 55: 993.
25. Gulanikar AC, MacDonald AS, Sungurtekin U, et al. The incidence and impact of early rejection episodes on graft outcome in recipients of first cadaveric kidney transplants. Transplantation 1992; 53: 323.
26. Matas AJ, Sibley R, Mauer SM, et al. Pre-discharge, post-transplant kidney biopsy does not predict rejection. J Surg Res 1982; 32: 269.
27. Chavers BM, Reinsmoen NL, Mauer SM, et al. High incidence of histologically-defined renal allograft rejection in asymptomatic patients following treatment. American Society of Transplant Physicians meeting, 1993: 261.
28. Rush DN, Jeffery JR, Gough J. Sequential protocol biopsies in renal transplant patients. Transplantation 1995; 59: 511.
29. Isoniemi H, Krogerus L, von Willebrand E, et al. Renal allograft immunosuppression: VI. Triple drug therapy versus immunosuppressive double drug combinations: histopathological findings in renal allografts. Transplant Int 1991; 4: 151.
30. Burdick JF, Beschorner WE, Smith WJ, et al. Characteristics of early routine renal allograft biopsies. Transplantation 1984; 38: 679.